A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.

Bruno Ramos-MolinaDaniel Castellano-CastilloOscar PastorLuis Ocaña-WilhelmiDiego Fernández-GarcíaManuel Romero-GómezFernando CardonaFrancisco J Tinahones

Published in: Obesity surgery (2020)

Our study indicates that the serum sphingomyelin levels could be related to the status of non-alcoholic fatty liver disease and that certain sphingomyelin species may be used for the follow-up of obese patients with NASH after sleeve gastrectomy.

Keyphrases

weight loss
metabolic syndrome
type diabetes
insulin resistance
adipose tissue
liver injury
drug induced
liver fibrosis
early onset
skeletal muscle
obese patients